Significant Ownership of Stonepine Capital Management, LLC

Signature - Title
/s/ Jon M. Plexico - Managing Member
Location
Bend, OR
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Stonepine Capital Management, LLC.

Notify me when Stonepine Capital Management, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Stonepine Capital Management, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNRX Quoin Pharmaceuticals, Ltd. Ordinary Shares 9.9% $62,800,787 3,030,926 Stonepine Capital Management, LLC 10 Dec 2025
INAB IN8BIO, Inc. Common Stock 9.9% $1,975,660 1,007,990 Stonepine Capital Management, LLC 19 Dec 2025
AYTU AYTU BIOPHARMA, INC Common Stock 9.9% $1,975,217 906,063 Stonepine Capital Management, LLC 30 Jun 2025
EDSA Edesa Biotech, Inc. Common Stock 9.9% $1,636,780 693,551 Stonepine Capital Management, LLC 13 Feb 2025
OPTN OptiNose, Inc. Common Stock 7.8% $7,176,688 +$1,819,909 788,647 +34% Stonepine Capital Management, LLC 31 Mar 2025
TELA TELA Bio, Inc. Common Stock 6% $2,211,913 2,353,099 Stonepine Capital Management, LLC 31 Dec 2024
SRZN Surrozen, Inc./DE Common Stock 5.8% $4,481,532 +$1,552,639 508,687 +53% Stonepine Capital Management, LLC 30 Jun 2025
CNSP CNS Pharmaceuticals, Inc. Common Stock 5.6% $289,980 32,220 Stonepine Capital Management, LLC 29 Oct 2025
KZR Kezar Life Sciences, Inc. Common Stock 5.2% $1,625,904 377,240 Stonepine Capital Management, LLC 02 Sep 2025
CALC CalciMedica, Inc. Common Stock 4.6% $949,295 -$170,674 628,672 -15% Stonepine Capital Management, LLC 31 Mar 2025
VSTM Verastem, Inc. Common Stock 4.3% $23,576,383 -$1,441,948 2,670,032 -5.8% Stonepine Capital Management, LLC 30 Sep 2025
APRE Aprea Therapeutics, Inc. Common Stock 4.3% $418,978 -$82,213 239,416 -16% Stonepine Capital Management, LLC 31 Mar 2025
INO Inovio Pharmaceuticals, Inc. Common Stock 3.8% $2,683,444 -$900,721 1,434,997 -25% Stonepine Capital Management, LLC 31 Mar 2025

Schedules 13D/G Reported by Stonepine Capital Management, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.